礼来中国回应替尔泊肽产能:工厂日夜运转满足患者需求

美港电讯
25 Dec 2024

【礼来中国回应替尔泊肽产能:工厂日夜运转满足患者需求】金十数据12月25日讯,目前多家电商平台已经有礼来葡萄糖依赖性促胰岛素多肽(GIP)/ 胰高糖素样肽-1(GLP-1)受体激动剂替尔泊肽(商品名:穆峰达)的诊疗拿药服务。替尔泊肽的适应证包括糖尿病、减重,目前平台各个商家的价格有所差异。礼来中国表示,该药是一款自费药物,具体价格请参照各大医药机构的定价。对于该药的产能供应,礼来中国表示,礼来每天都在生产运输大量的替尔泊肽,这一量级是史无前例的,以满足患者的需求。工厂正在日夜不停运转,新的制造设施也在连夜建设中。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10